Ausgabe 2/2009
Inhalt (10 Artikel)
Review
Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina
Usha K. Prasad, David Gray, Henry Purcell
Review
Drug evaluation: Vildagliptin-metformin single-tablet combination
Abd A. Tahrani, Milan K. Piya, Anthony H. Barnett
Review
Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review
Wim Verbeeck, Siegfried Tuinier, Geertruida E. Bekkering
Original Research
Cost-effectiveness analysis of lopinavir/ritonavir and atazanavir+ritonavir regimens in the CASTLE study
Kit N. Simpson, Rukmini Rajagopalan, Birgitta Dietz
Original Research
Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial
Jean-Louis Selam, Luigi F. Meneghini
Original Research
Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab
Alvaro P. C. Lupinacci, Jorge I. Calzada, Mohammad Rafieetery, Steve Charles, Peter A. Netland
Original Research
Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy
Maureen J. Lage, Rosalind Fabunmi, Kristina S. Boye, Derek A. Misurski
Original Research
Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist
Andrew E. Denker, Gaetano Morelli, Laura K. Vessey, Susie Li, Jinyu Yuan, Stephanie Dunbar, Nicole M. Lewis, William Taggart, John A. Wagner
Original Research
Dynamic splinting after treatment with botulinum toxin type-A: A randomized controlled pilot study
Jenny M. Lai, Gerard E. Francisco, F. Buck Willis